ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 84 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,751,000 | +16.1% | 65,683 | +5.6% | 0.79% | +7.9% |
| Q4 2017 | $4,093,000 | -12.1% | 62,172 | -33.1% | 0.73% | +18.4% |
| Q3 2017 | $4,656,000 | +0.4% | 92,899 | -7.3% | 0.62% | -19.2% |
| Q2 2017 | $4,636,000 | +2.3% | 100,170 | -21.9% | 0.77% | +7.3% |
| Q1 2017 | $4,530,000 | -45.2% | 128,300 | +43.6% | 0.71% | -25.2% |
| Q1 2015 | $8,272,000 | +11.2% | 89,335 | -51.5% | 0.96% | -8.0% |
| Q4 2014 | $7,442,000 | +341.4% | 184,020 | +167.0% | 1.04% | +202.6% |
| Q3 2014 | $1,686,000 | – | 68,921 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |